Morphine Versus Morphine-promethazine Combination for Acute Low Back Pain Relief in the Adult Emergency Department
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01129934|
Recruitment Status : Unknown
Verified May 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Not yet recruiting
First Posted : May 25, 2010
Last Update Posted : May 25, 2010
|Condition or disease||Intervention/treatment||Phase|
|Low Back Pain||Drug: Morphine-Promethazine Drug: morphine||Phase 4|
Acute low back pain is a common problem in the emergency department and pain relief is usually the first step in patients' management. Numerous medication options are available for acute LBP relief,each class of medication has its associated benefits and harms.Controversy remains regarding the optimal analgesic treatment.Anxiety has been found to be a predictive factor of pain intensity in patients with acute low back pain and anxiolysis by non-pharmacological measures has been shown to have a positive effect on pain management in the ED setting.
Promethazine is a first-generation H1 receptor antagonist of the phenothiazine chemical class used commonly as an antihistamine antiemetic. It has a strong anxiolytic-sedative effect and its safety and efficacy in managing anxiety related to medical procedures is well documented.It may be reasonable to assume that pharmacological anxiolysis with promethazine may assist in alleviation of acute pain in the strenuous environment of the ED.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||Pharmacological Anxiolysis With Promethazine as an Adjunctive Therapy for Acute Low Back Pain in the Adult Emergency Department|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||December 2011|
|Estimated Study Completion Date :||January 2013|
Pain relief by administration of morphine-promethazine combination
administration of intravenous morphine 0.1mg/kg and promethazine 12.5 mg in a 500 Ml 0.9% saline
Other Name: morphine-phenergan
Active Comparator: morphine
pain relief by administration of morphine
Administration of intravenous morphine 0.1 mg/kg
Other Name: morphine as a single drug
- Pain relief [ Time Frame: Up to 24 hours (before analgesia administration and on discharge from the ED or admission to the hospital) ]Pain scores before and after treatment will be assessed on a 100mm VAS. The difference will be regarded as pain relief.
- Ambulatory status [ Time Frame: Up to 24 hours (before analgesia administration and on discharge from the ED or admission to the hospital) ]Most patients who suffer from acute LBP are in severe pain and are unable to ambulate. The ambulatory status of every patient (e.g., able to walk independently, using a can, wheelchair, laying down and unable to sit or stand up)will be recorded before and after treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01129934
|Contact: Ofir Uri, M.Dfirstname.lastname@example.org|
|Tel-Aviv Sourasky Medical Center||Not yet recruiting|
|Contact: Ofir Uri, M.D 972-52-4262285 email@example.com|
|Contact: Pinchas Halpern, M.D 972-52-4266681 firstname.lastname@example.org|
|Principal Investigator: Pinchas Halpern, M.D|
|Sub-Investigator: Ofir Uri, M.D|
|Sub-Investigator: Amir Shapira, M.D|
|Study Chair:||Pinchas Halpern, M.D||Tel-Aviv Medical Center, Tel-Aviv University, Israel|